πŸ‡ΊπŸ‡Έ FDA
Patent

US 11555189

Antisense oligomer compounds

granted A61KA61K47/6455

Quick answer

US patent 11555189 (Antisense oligomer compounds) held by Sarepta Therapeutics, Inc. expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K47/6455